COVID-19 - A vascular disease.

Area of Science:

• Cardiovascular Science
• Infectious Diseases
• Pathology

Background:

• Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) infection is linked to multi-systemic complications.
• Growing evidence indicates that SARS-CoV-2 directly impacts the vascular endothelium, contributing to disease severity.
• Endothelial dysfunction is increasingly recognized as a critical mechanism in COVID-19 pathogenesis.

Purpose of the Study:

• To highlight the role of SARS-CoV-2-induced endothelial injury in COVID-19.
• To explore the therapeutic potential of targeting vascular system dysfunction in SARS-CoV-2 infection.
• To discuss the implications of endothelial damage for long-term COVID-19 effects.

Main Methods:

• Review of current scientific literature on SARS-CoV-2 and vascular pathology.
• Analysis of studies investigating endothelial cell responses to SARS-CoV-2.
• Synthesis of evidence linking viral infection to endothelial dysfunction and systemic effects.

Main Results:

• SARS-CoV-2 infection demonstrably causes endothelial injury across multiple organ systems.
• This injury contributes significantly to the multi-system dysfunction observed in COVID-19 patients.
• Endothelial dysfunction is implicated in both acute disease severity and the development of long-term sequelae.

Conclusions:

• Endothelial injury is a pivotal mechanism in SARS-CoV-2 pathogenesis.
• Therapeutic strategies focused on the vascular system may offer effective treatment options for COVID-19.
• Addressing endothelial dysfunction is essential for managing both acute and chronic manifestations of SARS-CoV-2 infection.